BRPI0519426A2 - linhagem conferindo propriedades antidoenÇa À composiÇço de cÉlula bacteriana e hospedeira - Google Patents

linhagem conferindo propriedades antidoenÇa À composiÇço de cÉlula bacteriana e hospedeira

Info

Publication number
BRPI0519426A2
BRPI0519426A2 BRPI0519426-1A BRPI0519426A BRPI0519426A2 BR PI0519426 A2 BRPI0519426 A2 BR PI0519426A2 BR PI0519426 A BRPI0519426 A BR PI0519426A BR PI0519426 A2 BRPI0519426 A2 BR PI0519426A2
Authority
BR
Brazil
Prior art keywords
cell composition
lineage
conferring
bacterial
host cell
Prior art date
Application number
BRPI0519426-1A
Other languages
English (en)
Inventor
Takehiro Miwa
Hiroshi Watanabe
Mamoru Ishihara
Tsuneo Hino
Narito Asanuma
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of BRPI0519426A2 publication Critical patent/BRPI0519426A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LINHAGEM CONFERINDO PROPRIEDADES ANTIDOENÇA À COMPOSIÇçO DE CÉLULA BACTERIANA E HOSPEDEIRA. Uma nova composiçào de célula bacteriana caracterizada por compreender células bacteriana de Butyri vi brio fibriosolvens possuindo a habilidade de produzir ácido butirico, sua cultura ou seu extrato; um método de inibir oncogênese, um método de ativar imunidade, um método de prevenir/tratar um patógeno, um método de prevenir/tratar uma doença inflamatória do intestino e um método de prevenir/tratar uma doença alérgica usando a mesma.
BRPI0519426-1A 2004-12-28 2005-12-28 linhagem conferindo propriedades antidoenÇa À composiÇço de cÉlula bacteriana e hospedeira BRPI0519426A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004379693 2004-12-28
PCT/JP2005/024144 WO2006070891A1 (ja) 2004-12-28 2005-12-28 宿主に対して抗病性を付与する新規な菌株および菌体組成物

Publications (1)

Publication Number Publication Date
BRPI0519426A2 true BRPI0519426A2 (pt) 2009-01-20

Family

ID=36615002

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519426-1A BRPI0519426A2 (pt) 2004-12-28 2005-12-28 linhagem conferindo propriedades antidoenÇa À composiÇço de cÉlula bacteriana e hospedeira

Country Status (12)

Country Link
US (1) US8728794B2 (pt)
EP (1) EP1835021B1 (pt)
JP (1) JP4953824B2 (pt)
KR (1) KR101102914B1 (pt)
CN (1) CN101124318B (pt)
AT (1) ATE498679T1 (pt)
BR (1) BRPI0519426A2 (pt)
DE (1) DE602005026452D1 (pt)
DK (1) DK1835021T3 (pt)
ES (1) ES2358746T3 (pt)
PT (1) PT1835021E (pt)
WO (1) WO2006070891A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110059168A1 (en) * 2009-09-09 2011-03-10 Ang Sam Method for correcting intestinal glutamine synthetase deficiency
KR101371554B1 (ko) 2011-12-21 2014-03-10 한국해양과학기술원 항균 활성을 포함한 다양한 생리 활성을 가지는 신규의 지방산, 이 지방산을 생성하는 해양 미생물 및 이 지방산의 제조방법
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
KR101364747B1 (ko) * 2013-12-03 2014-02-27 한국해양과학기술원 항균 활성을 포함한 다양한 생리 활성을 가지는 신규의 지방산, 이 지방산을 생성하는 해양 미생물 및 이 지방산의 제조방법
KR101364748B1 (ko) 2013-12-03 2014-02-27 한국해양과학기술원 항균 활성을 포함한 다양한 생리 활성을 가지는 신규의 지방산, 이 지방산을 생성하는 해양 미생물 및 이 지방산의 제조방법
KR101364749B1 (ko) 2013-12-03 2014-02-27 한국해양과학기술원 항균 활성을 포함한 다양한 생리 활성을 가지는 신규의 지방산, 이 지방산을 생성하는 해양 미생물 및 이 지방산의 제조방법
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
KR20170103920A (ko) * 2015-01-09 2017-09-13 바게닝겐 유니버시테이트 위장관, 대사성 및/또는 기타 질환의 치료 및/또는 예방을 위한 박테리아-함유 조성물 및 이의 사용 방법
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CA3106315A1 (en) 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5104198A (en) 1996-11-05 1998-05-29 Wisconsin Alumni Research Foundation Use of conjugated linoleic acid to enhance natural killer lymphocyte function
JP2003073269A (ja) 1998-03-17 2003-03-12 Conlinco Inc 共役リノール酸組成物
US6696584B2 (en) 1998-05-04 2004-02-24 Natural Asa Isomer enriched conjugated linoleic acid compositions
WO2002080947A1 (fr) 2001-04-06 2002-10-17 Kyodoken Institute For Animal Science Research & Development Compositions contenant une bacterie pouvant convertir de l'acide lactique en acide butyrique, et methode utilisant ces compositions pour prevenir ou traiter l'hyperlactacidemie dans le systeme digestif ou le cancer du colon
US6677470B2 (en) 2001-11-20 2004-01-13 Natural Asa Functional acylglycerides
KR100516377B1 (ko) * 2002-04-12 2005-09-26 (주)케비젠 공역화 리놀렌산을 생산하는 신규한 균주, 이를 함유하는 캡슐제 및 이를 이용한 기능성 식품
ES2204328B1 (es) 2002-10-04 2005-09-01 Consejo Sup. De Invest. Cientificas Procedimiento de produccion de acidos grasos polinsaturados con levaduras por incorporacion de sustratos olefinicos o acetilenicos.
CN1248697C (zh) * 2003-11-13 2006-04-05 荀涣仁 一种治疗慢性肠炎的药物组合物及其制备方法

Also Published As

Publication number Publication date
EP1835021A4 (en) 2008-11-05
WO2006070891A1 (ja) 2006-07-06
PT1835021E (pt) 2011-04-29
US8728794B2 (en) 2014-05-20
CN101124318A (zh) 2008-02-13
ES2358746T3 (es) 2011-05-13
EP1835021B1 (en) 2011-02-16
ATE498679T1 (de) 2011-03-15
DK1835021T3 (da) 2011-04-18
CN101124318B (zh) 2013-01-09
JPWO2006070891A1 (ja) 2008-06-12
JP4953824B2 (ja) 2012-06-13
KR101102914B1 (ko) 2012-01-10
US20080095745A1 (en) 2008-04-24
EP1835021A1 (en) 2007-09-19
KR20070091212A (ko) 2007-09-07
DE602005026452D1 (de) 2011-03-31

Similar Documents

Publication Publication Date Title
EP1796666A4 (en) METHOD AND COMPOSITIONS FOR TREATING HYPERLIPIDEMIA
CY2018013I1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
EP1881839A4 (en) COMPOSITIONS FROM BACUCHIOL AND METHOD FOR THE PRODUCTION THEREOF
EP1863507A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACNE
NO20076003L (no) TGF-beta 1 spesifikke antistoffer
EP1765288A4 (en) METHOD FOR THE TREATMENT OF ENDOBRONCHIAL INFECTIONS
ATE530669T1 (de) Markierte mikroorganismen und entsprechende markierungsverfahren
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
NO20071127L (no) Triazoloftalaziner
NO20082594L (no) Pyrimidinylbenzotiofenforbindelser
TW200611699A (en) Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
EP1755391A4 (en) METHOD AND COMPOSITIONS FOR TREATING NERVOUS ELEMENTS
DE602005018981D1 (de) Verfahren zur Herstellung von L-Cystein, und L-Cystein-produzierender Mikroorganismus
UA101478C2 (ru) Соединения, полезные как ингибиторы raf-киназы
WO2008149237A3 (en) Method for methylation analysis
EA200802054A1 (ru) Ингибиторы фермента
WO2006081276A8 (en) 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
BRPI0519426A2 (pt) linhagem conferindo propriedades antidoenÇa À composiÇço de cÉlula bacteriana e hospedeira
DK2169050T3 (da) Fremgangsmåde til fremstilling af ikke-allergiske probiotiske bakteriekulturer samt deres anvendelse
EP1774895A4 (en) ENDOSCOPE AND METHOD FOR REPAIRING AN ENDOSCOPE
EP1899198A4 (en) MECHANISM FOR DETACHABLE MOUNTING AND USE METHOD
EP2056849A4 (en) METHOD AND COMPOSITIONS FOR TREATING IGE-MEDIATED ILLNESSES
EP1720893A4 (en) COMPOSITIONS AND METHODS FOR THE SYSTEMIC TREATMENT OF ARTHRITIS
WO2007103468A3 (en) Use of vx-702 for treating rheumatoid arthritis
NO20073276L (no) Metode for fremstilling av aminoetoksybenzylalkoholer

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: MEIJI SEIKA PHARMA CO., LTD. (JP)

Free format text: NOME ALTERADO DE: MEIJI SEIKA KAISHA LTD.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: C12R 1/01 (2006.01), A23K 10/16 (2016.01), A23K 10